Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-24 Brunn Carsten President and CEO Grant or award · Employee Stock Option (right to buy) +163,000 163,000
2021-09-20 Tan Kevin Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +750,000 750,000
2021-09-02 Brunn Carsten President and CEO Sale −4,523 $4.51 $20K 229,372
2021-09-01 Brunn Carsten President and CEO Option exercise +10,937 233,895
2021-09-01 Brunn Carsten President and CEO Option exercise · Restricted Stock Units −10,937 54,688
2021-08-18 BARABE TIMOTHY C Director Purchase +9,000 $4.00 $36K 190,013
2021-06-23 DeSilva Nishan M Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-06-02 Brunn Carsten President and CEO Sale −4,806 $4.38 $21K 222,958
2021-06-01 Brunn Carsten President and CEO Option exercise +10,938 227,764
2021-06-01 Brunn Carsten President and CEO Option exercise · Restricted Stock Units −10,938 65,625
2021-05-26 TRABER PETER G Chief Medical Officer Purchase +20,000 $3.99 $80K 135,500
2021-05-26 SPRINGER TIMOTHY A Director Purchase +926,170 $4.00 $3.7M 19,154,427
2021-05-25 SPRINGER TIMOTHY A Director Purchase +383,830 $3.55 $1.4M 18,228,257
2021-05-25 TRABER PETER G Chief Medical Officer Purchase +5,000 $3.48 $17K 115,500
2021-05-24 SPRINGER TIMOTHY A Director Purchase +590,000 $3.38 $2.0M 17,844,427
2021-05-24 TRABER PETER G Chief Medical Officer Purchase +12,500 $3.32 $41K 110,500
2021-05-21 SPRINGER TIMOTHY A Director Purchase +2,773,479 $3.19 $8.8M 17,254,427
2021-05-07 Kishimoto Takashi Kei Chief Scientific Officer Option exercise +13,629 $2.77 $38K 177,778
2021-05-07 Kishimoto Takashi Kei Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −13,629 0
2021-03-30 ANDO GORAN Director Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 24 of 25 · 495 trades